56
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Real-world comparison of health care utilization between duloxetine and pregabalin initiators with fibromyalgia

, , , &
Pages 37-46 | Published online: 09 Jan 2014

References

  • SunPPengXSunSDirect medical costs and medication compliance among fibromyalgia patients: duloxetine initiators vs pregabalin initiatorsPain Pract Epub3142013
  • SunPZhaoYZhaoZWatsonPMedication dosing patterns associated with duloxetine and pregabalin among patients with fibromyalgiaCurr Med Res Opin20112791793180121810060
  • ZhaoYSunPBernauerMComparing common reasons for inpatient and outpatient visits between commercially-insured duloxetine or pregabalin initiators with fibromyalgiaJ Pain Res2015443451
  • ZhaoYSunPWatsonPMitchellBSwindleRComparison of medication adherence and healthcare costs between duloxetine and pregabalin initiators among patients with fibromyalgiaPain Pract201111320421620807351
  • MarcusDARichardsKLChambersJFBhowmickAFibromyalgia family and relationship impact exploratory surveyMusculoskeletal Care201311312513423172797
  • ForsEALandmarkTBakkeØContextual and time dependent pain in fibromyalgia: an explorative studyBMC Res Notes2012564423163972
  • Castro-SánchezAMMatarán-PeñarrochaGALópez-RodríguezMMLara-PalomoICArendt-NielsenLFernández-de-las-PeñasCGender differences in pain severity, disability, depression, and widespread pressure pain sensitivity in patients with fibromyalgia syndrome without comorbid conditionsPain Med201213121639164723171037
  • AuquierLBontouxDLöoHLa fibromyalgie. [Fibromyalgia]Rev Med Interne2008292161168 French17976867
  • WolfeFHawleyDJGoldenbergDLRussellIJBuskilaDNeumannLThe assessment of functional impairment in fibromyalgia (FM): Rasch analyses of 5 functional scales and the development of the FM Health Assessment QuestionnaireJ Rheumatol20002781989199910955343
  • WolfeFSmytheHAYunusMBThe American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria CommitteeArthritis Rheum19903321601722306288
  • Al-AllafAWWork disability and health system utilization in patients with fibromyalgia syndromeJ Clin Rheumatol200713419920117762453
  • RobinsonRLJonesMLIn search of pharmacoeconomic evaluations for fibromyalgia treatments: a reviewExpert Opin Pharmacother2006781027103916722813
  • BennettRMJonesJTurkDCRussellIJMatallanaLAn internet survey of 2,596 people with fibromyalgiaBMC Musculoskelet Disord200782717349056
  • ShaverJLWilburJRobinsonFPWangEBuntinMSWomen’s health issues with fibromyalgia syndromeJ Womens Health (Larchmt)20061591035104517125422
  • RutledgeDNJonesKJonesCJPredicting high physical function in people with fibromyalgiaJ Nurs Scholarsh200739431932418021131
  • BergerADukesEMartinSEdelsbergJOsterGCharacteristics and healthcare costs of patients with fibromyalgia syndromeInt J Clin Pract20076191498150817655684
  • PantonLBKingsleyJDTooleTA comparison of physical functional performance and strength in women with fibromyalgia, age- and weight-matched controls, and older women who are healthyPhys Ther200686111479148817079747
  • VerbuntJAPernotDHSmeetsRJDisability and quality of life in patients with fibromyalgiaHealth Qual Life Outcomes20086818211701
  • KurtzeNGundersenKTSvebakSQuality of life, functional disability and lifestyle among subgroups of fibromyalgia patients: the significance of anxiety and depressionBr J Med Psychol199972Pt 447148410616131
  • WolfeFPetriMAlarcónGSFibromyalgia, systemic lupus erythematosus (SLE), and evaluation of SLE activityJ Rheumatol2009361828819004039
  • Better MedicinePrevalence and incidence of fibromyalgia Available from: http://www.localhealth.com/article/fibromyalgiaAccessed May 5, 2009
  • National Fibromyalgia AssociationPrevalence of fibromyalgia Available from: http://fmaware.org/PageServera6cc.html?pagename=fibromyalgia_affectedAccessed May 5, 2009
  • BrancoJCBannwarthBFaildeIPrevalence of fibromyalgia: a survey in five European countriesSemin Arthritis Rheum201039644845319250656
  • BannwarthBBlotmanFRoué-Le LayKCaubèreJPAndréETaïebCFibromyalgia syndrome in the general population of France: a prevalence studyJoint Bone Spine200976218418718819831
  • MasAJCarmonaLValverdeMRibasBEPISER Study GroupPrevalence and impact of fibromyalgia on function and quality of life in individuals from the general population: results from a nationwide study in SpainClin Exp Rheumatol200826451952618799079
  • TodaKThe prevalence of fibromyalgia in Japanese workersScand J Rheumatol200736214014417476621
  • WeirPTHarlanGANkoyFLThe incidence of fibromyalgia and its associated comorbidities: a population-based retrospective cohort study based on International Classification of Diseases, 9th Revision codesJ Clin Rheumatol200612312412816755239
  • TopbasMCakirbayHGulecHAkgolEAkICanGThe prevalence of fibromyalgia in women aged 20–64 in TurkeyScand J Rheumatol200534214014416095011
  • SardiniSGhirardiniMBetelemmeLArpinoCFattiFZaniniFStudio epidemiologico sulla fibromialgia primaria in eta pediatrica. [Epidemiological study of a primary fibromyalgia in pediatric age.]Minerva Pediatr19964812543550 Italian9091773
  • WolfeFRossKAndersonJRussellIJHebertLThe prevalence and characteristics of fibromyalgia in the general populationArthritis Rheum199538119287818567
  • KimSKKimSHLeeCKEffect of fibromyalgia syndrome on the health-related quality of life and economic burden in KoreaRheumatology (Oxford)201352231132023024016
  • RobinsonRLKroenkeKMeasePBurden of illness and treatment patterns for patients with fibromyalgiaPain Med201213101366137622958298
  • PerrotSSchaeferCKnightTHufstaderMChandranABZlatevaGSocietal and individual burden of illness among fibromyalgia patients in France: association between disease severity and OMERACT core domainsBMC Musculoskelet Disord2012132222340435
  • ChandranASchaeferCRyanKBaikRMcNettMZlatevaGThe comparative economic burden of mild, moderate, and severe fibromyalgia: results from a retrospective chart review and cross-sectional survey of working-age US adultsJ Manag Care Pharm201218641542622839682
  • SchaeferCChandranAHufstaderMThe comparative burden of mild, moderate and severe fibromyalgia: results from a cross-sectional survey in the United StatesHealth Qual Life Outcomes201197121859448
  • SpaethMEpidemiology, costs, and the economic burden of fibromyalgiaArthritis Res Ther200911311719591654
  • KleinmanNHarnettJMelkonianABurden of fibromyalgia and comparisons with osteoarthritis in the workforceJ Occup Environ Med200951121384139319952796
  • AnnemansLLe LayKTaïebCSocietal and patient burden of fibromyalgia syndromePharmacoeconomics200927754755919663526
  • DoronYPelegRPelegANeumannLBuskilaDThe clinical and economic burden of fibromyalgia compared with diabetes mellitus and hypertension among Bedouin women in the NegevFam Pract200421441541915249530
  • CarvilleSFArendt-NielsenSBliddalHEULAREULAR evidence-based recommendations for the management of fibromyalgia syndromeAnn Rheum Dis200867453654117644548
  • GuymerEKLittlejohnGOFibromyalgia. Diagnosis and managementAustralas Chiropr Osteopathy2002102818417987178
  • SumptonJEMoulinDEFibromyalgia: presentation and management with a focus on pharmacological treatmentPain Res Manag200813647748319225604
  • BuckhardtCSGoldenbergDCroffordLGuideline for the Management of Fibromyalgia Syndrome. Pain in Adults and Children APS Clinical Practice Guideline Series No. 4Glenview, ILAmerican Pain Society2005
  • HäuserWThiemeKTurkDCGuidelines on the management of fibromyalgia syndrome – a systematic reviewEur J Pain201014151019264521
  • ForsethK KØGranJTManagement of fibromyalgia: what are the best treatment choices?Drugs200262457759211893227
  • BrosseauLWellsGATugwellPOttawa Panel MembersOttawa Panel evidence-based clinical practice guidelines for aerobic fitness exercises in the management of fibromyalgia: part 1Phys Ther200888785787118497301
  • BrosseauLWellsGATugwellPOttawa Panel MembersOttawa Panel evidence-based clinical practice guidelines for strengthening exercises in the management of fibromyalgia: part 2Phys Ther200888787388618497302
  • CroffordLJPain management in fibromyalgiaCurr Opin Rheumatol200820324625018388513
  • CroffordLJRowbothamMCMeasePJPregabalin 1008–1105 Study GroupPregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trialArthritis Rheum20055241264127315818684
  • CalandreEPMorillas-ArquesPRodriguez-LopezCMRico-VillademorosFHidalgoJPregabalin augmentation of quetiapine therapy in the treatment of fibromyalgia: an open-label, prospective trialPharmacopsychiatry2007402687117447176
  • CroffordLJMeasePJSimpsonSLFibromyalgia relapse evaluation and efficacy for durability of meaningful relief (FREEDOM): a 6-month, double-blind, placebo-controlled trial with pregabalinPain2008136341943118400400
  • MeasePJRussellIJArnoldLMA randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with fibromyalgiaJ Rheumatol200835350251418278830
  • García-CampayoJSerrano-BlancoARoderoBEffectiveness of the psychological and pharmacological treatment of catastrophization in patients with fibromyalgia: a randomized controlled trialTrials2009102419389246
  • RussellIJMeasePJSmithTREfficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trialPain2008136343244418395345
  • ArnoldLMRosenAPritchettYLA randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorderPain20051191–351516298061
  • ArnoldLMLuYCroffordLJA double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorderArthritis Rheum20045092974298415457467
  • ClauwDJMeasePPalmerRHGendreauRMWangYMilnacipran for the treatment of fibromyalgia in adults: a 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trialClin Ther200830111988200419108787
  • GendreauRMThornMDGendreauJFEfficacy of milnacipran in patients with fibromyalgiaJ Rheumatol200532101975198516206355
  • VittonOGendreauMGendreauJKranzlerJRaoSGA double-blind placebo-controlled trial of milnacipran in the treatment of fibromyalgiaHum Psychopharmacol200419Suppl 1S27S3515378666
  • ReedCBirnbaumHGIvanovaJIReal-world role of tricyclic antidepressants in the treatment of fibromyalgiaPain Pract201212753354022226400
  • GoreMTaiKSChandranAZlatevaGLeslieDClinical characteristics, pharmacotherapy, and healthcare resource use among patients with fibromyalgia newly prescribed pregabalin or tricyclic antidepressantsJ Med Econ2012151324421970698
  • GoreMTaiKSChandranAZlatevaGLeslieDClinical comorbidities, treatment patterns, and healthcare costs among patients with fibromyalgia newly prescribed pregabalin or duloxetine in usual careJ Med Econ2012151193121970699
  • BurkeJPSanchezRJJoshiAVCappelleriJCKulakodluMHalpernRHealth care costs in patients with fibromyalgia on pregabalin vs duloxetinePain Pract2012121142221615857
  • HarnettJMargolisJCaoZReal-world evaluation of health-care resource utilization and costs in employees with fibromyalgia treated with pregabalin or duloxetinePain Pract201111321722921199319
  • Rodriguez-RevengaLMadrigalIBlanch-RubióJScreening for the presence of FMR1 premutation alleles in women with fibromyalgiaGene2013512230530823111161
  • BergerASadoskyADukesEMEdelsbergJZlatevaGOsterGPatterns of healthcare utilization and cost in patients with newly diagnosed fibromyalgiaAm J Manag Care201016Suppl 5S126S13720586521
  • BergerASadoskyADukesEMartinSEdelsbergJOsterGCharacteristics and patterns of healthcare utilization of patients with fibromyalgia in general practitioner settings in GermanyCurr Med Res Opin20082492489249918664319
  • HorndaschSHohe Inanspruchnahme des Gesundheitswesens durch Fibromyalgiepatienten. [High utilization of health care services by fibromyalgia patients.]Schmerz20092317071 German19153777
  • PalacioAUribeCLLiHFinancial and clinical characteristics of fibromyalgia: a case-control comparisonAm J Manag Care201016Suppl 5S118S12520586520
  • SanchezRJUribeCLiHLongitudinal evaluation of health care utilization and costs during the first three years after a new diagnosis of fibromyalgiaCurr Med Res Opin201127366367121241205
  • WhiteKPNelsonWRHarthMOstbyeTSpeechleyMDoes the label “fibromyalgia” alter health status, function, and health service utilization? A prospective, within-group comparison in a community cohort of adults with chronic widespread painArthritis Rheum200247326026512115155
  • WolfeFAndersonJHarknessDA prospective, longitudinal, multicenter study of service utilization and costs in fibromyalgiaArthritis Rheum1997409156015709324009
  • HudsonJIGoldenbergDLPopeHGJrKeckPEJrSchlesingerLComorbidity of fibromyalgia with medical and psychiatric disordersAm J Med19929243633671558082
  • RaphaelKGJanalMNNayakSComorbidity of fibromyalgia and posttraumatic stress disorder symptoms in a community sample of womenPain Med200451334114996235
  • BradleyLAPsychiatric comorbidity in fibromyalgiaCurr Pain Headache Rep200592798615745615
  • Chamizo-CarmonaE¿Existe asociación entre la fibromialgia, el aumento de la comorbilidad por enfermedad neoplásica, cardiovascular e infecciones, y el de la mortalidad? [Is there an association between fibromyalgia and an increase in comorbidity: neoplastic and cardiovascular diseases, infections and mortality?]Reumatol Clin200514200210 Spanish21794265
  • BuskilaDCohenHComorbidity of fibromyalgia and psychiatric disordersCurr Pain Headache Rep200711533333817894922
  • Gil YuberoJLlensa CubarsíIMas MarquèsMBuñuel AlvarezJCComorbilidad registrada en los pacientes diagnosticados de fibromialgia en un centro de atención primaria. [Comorbidity recorded in patients diagnosed with fibromyalgia at a primary care centre.]Aten Primaria2007394217 Spanish17428429
  • WhiteLABirnbaumHGKaltenboeckATangJMallettDRobinsonRLEmployees with fibromyalgia: medical comorbidity, healthcare costs, and work lossJ Occup Environ Med2008501132418188077
  • de TommasoMSardaroMSerpinoCFibromyalgia comorbidity in primary headachesCephalalgia200929445346419170692
  • GonzálezEElorzaJFaildeIFibromyalgia and psychiatric comorbidity: their effect on the quality of life patientsActas Esp Psiquiatr2010385295300 Spanish.21117004
  • ShillamCRDupree JonesKMillerLFibromyalgia symptoms, physical function, and comorbidity in middle-aged and older adultsNurs Res201160530931721873914
  • RosenbaumPRRubinDBThe central role of the propensity score in observational studies for causal effectsBiometrika19837014155
  • GuoSYFraserMWPropensity Score Matching and Related Models. Propensity Score Analysis: Statistical Methods and ApplicationsLos AngelesSEGA2010145149
  • D’AgostinoRBJrPropensity score methods for bias reduction in the comparison of a treatment to a non-randomized control groupStat Med19981719226522819802183
  • DehejiaRHWahbaSPropensity score-matching methods for nonexperimental causal studiesRev Econ Stat2002841151161
  • KleinmanNLSanchezRJLynchWDCappelleriJCBerenIAJoshiAVHealth outcomes and costs among employees with fibromyalgia treated with pregabalin vs standard of carePain Pract201111654055121392253